GlobeNewswire Press Releases - EIN Presswire - Press Release Distribution Service

Published on November 8, 2025 - 18:11 GMT

RZoasis Announces the Launch of RZUSD, a Transparent Stablecoin Amid Growing Shift Away from Centralized Alternatives

DUBAI, United Arab Emirates, Nov. 08, 2025 (GLOBE NEWSWIRE) -- RZoasis, a next-generation Web3 infrastructure project, today announced the official launch of RZUSD, a transparent and independently backed stablecoin designed to meet the increasing demand …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on November 8, 2025 - 17:21 GMT

FLR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Fluor Corporation Investors to Secure Counsel Before Important Deadline ...

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fluor Corporation (NYSE: FLR) between February 18, 2025 and July 31, 2025, both dates inclusive (the “Class Period”), of …

Distribution channels: Consumer Goods, Law ...

Published on November 8, 2025 - 17:12 GMT

AI Meets Digital Assets: CreditBlockchain Launches Free Cloud Trial for XRP Investors Era

New York, NY, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Credit Blockchain, a global fintech company pioneering AI-driven digital finance, today announced the launch of its Free Cloud Trial Program, designed to introduce investors — particularly those in the XRP …

Distribution channels: IT Industry, Media, Advertising & PR ...

Published on November 8, 2025 - 17:02 GMT

Il SEV di ASTRAUX illumina l'EICMA 2025 e ridefinisce la mobilità urbana smart a partire da 6.590 €

MILANO, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Il veicolo elettrico smart (SEV) di ASTRAUX di ultima generazione ha rubato la scena all'EICMA 2025 di Milano, ridefinendo la mobilità urbana. Dotato di climatizzatore completo di serie e un'autonomia fino …

Distribution channels: Automotive Industry, Media, Advertising & PR ...

Published on November 8, 2025 - 16:45 GMT

Telitacicept Achieved Primary Endpoint of Reducing Proteinuria in Stage A of a Phase 3 Clinical Study for IgA Nephropathy in China

Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction in proteinuria, with a favorable safety profile Telitacicept demonstrated a 55% reduction in 24-hour urine protein-to-creatinine …

Distribution channels: Technology ...

Published on November 8, 2025 - 16:35 GMT

ROSEN, HIGHLY RANKED INVESTOR COUNSEL, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in ...

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, …

Distribution channels: Consumer Goods, Media, Advertising & PR ...

Published on November 8, 2025 - 16:30 GMT

Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and cardiometabolic diseases, including pericarditis and atherosclerosis Initial data from a Phase 1 study of MRT- …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 8, 2025 - 16:25 GMT

Tenaya Therapeutics Presents Promising Interim Clinical Data from MYPEAK™-1 Phase 1b/2a Clinical Trial of TN-201 Gene Therapy for ...

MyPEAK-1 Data Presented During Late-Breaking Session at AHA Scientific Sessions 2025 with Simultaneous Publication in Cardiovascular Research TN-201 Has Been Generally Well Tolerated at Both Doses Longer-term Follow Up of Cohort 1 Patients Showed …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 8, 2025 - 16:07 GMT

IGEL läutet neue Ära der EUC-Transformation und vertrauenswürdigen Endpunktsicherheit ein

Europas führende Veranstaltung zum Thema EUC und Endpunktsicherheit versammelt Microsoft, Omnissa, HP, Lenovo, Zscaler, Palo Alto Networks und weitere Unternehmen, um die Zukunft von Zero Trust, Kontinuität und widerstandsfähigem EUC voranzutreiben …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on November 8, 2025 - 16:07 GMT

PALOMAR HEALTH MEDICAL GROUP ALERT: Bragar Eagel & Squire, P.C. is Investigating the Palomar Health Medical Group Data Breach

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Data Breach Victims to Contact the Firm Click here to participate in the action. NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a …

Distribution channels: Consumer Goods, Law ...

Published on November 8, 2025 - 16:00 GMT

Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of ...

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, …

Distribution channels: Culture, Society & Lifestyle, Media, Advertising & PR ...

Published on November 8, 2025 - 16:00 GMT

Judo Bio’s Megalin-STRIKERs Achieve First Demonstration of Functional Pharmacodynamic Effects from Kidney Selective Gene Silencing ...

Data presented at Kidney Week 2025 showed single subcutaneous administration of megalin-STRIKERs resulted in increased excretion of disease-related solute levels lasting for at least 2 months Dr. Ravi Thadhani, internationally recognized nephrology …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on November 8, 2025 - 15:46 GMT

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart ...

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement Trial results consistent with prospective design of these antibodies to …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...

Published on November 8, 2025 - 15:46 GMT

AGL Investor News: If You Have Suffered Losses in agilon health, inc. (NYSE: AGL), You Are Encouraged to Contact The Rosen Law ...

NEW YORK, Nov. 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon …

Distribution channels: Consumer Goods, Law ...

Published on November 8, 2025 - 15:42 GMT

VFC CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Reminds VF Corporation Investors of the November 11th Deadline for ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In V.F. Corporation (VFC) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in VFC between October 27, 2022, …

Distribution channels: Consumer Goods, Law ...

Published on November 8, 2025 - 15:41 GMT

Acoramidis Significantly Reduces All-cause Mortality in the Overall ATTR-CM Variant and V142I (V122I) Populations

- Simultaneously published in JAMA Cardiology along with moderated posters at AHA, acoramidis demonstrated: 59% risk reduction in ACM in the ATTR-CM variant population at Month 42 (p=0.032) compared to patients initially randomized to placebo in the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...

Published on November 8, 2025 - 15:37 GMT

LANTHEUS CLASS ACTION DEADLINE: Bragar Eagel & Squire, P.C. Urgently Reminds Lantheus Stockholders to Contact the Firm Before ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Lantheus (LNTH) To Contact Him Directly To Discuss Their Options If you purchased or acquired Lantheus securities between November 6, 2024, to …

Distribution channels: Consumer Goods, Law ...

Published on November 8, 2025 - 15:19 GMT

BexBack Unlocks No-KYC 100x Leverage With New $100 Bonus for Beginners

SINGAPORE, Nov. 08, 2025 (GLOBE NEWSWIRE) -- BexBack , a leading cryptocurrency derivatives exchange, has announced a major promotion offering new users a $100 welcome bonus and a 100% deposit match to support higher capital efficiency in crypto futures …

Distribution channels: Banking, Finance & Investment Industry, Media, Advertising & PR ...

Published on November 8, 2025 - 15:00 GMT

Dancetime Launches Guide to Top 8 Outdoor Party Hire Essentials Amid Surge in Sydney Events

Sydney, NSW, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Dancetime, a leading event hire provider in New South Wales and Queensland, announced today the release of its definitive guide to the eight most in-demand party hire items, as outdoor events and weddings …

Distribution channels: Media, Advertising & PR, Travel & Tourism Industry ...

Published on November 8, 2025 - 14:56 GMT

CRISPR Therapeutics Announces Positive Phase 1 Clinical Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, ...

-Data presented in a late-breaking presentation at the American Heart Association (AHA) Scientific Sessions 2025- -Phase 1 clinical data for CTX310® demonstrate robust, dose-dependent reductions in circulating ANGPTL3 with a mean reduction from baseline of …

Distribution channels: Technology ...